ICO
Closed:

Targeted Oral Drug Delivery

Targeted Oral Drug Delivery

Reckitt is interested in research focused on the exploration of targeted approaches that will selectively enhance delivery of solid or liquid benefit agents into the pharyngeal, esophageal or colonic regions of the gastrointestinal tract, following oral delivery. In line with this Reckitt is also interested in research to further characterise the GI tract physiochemical environment, with a particular focus on these 3 target regions. A particular interest is on the specific mucosa and the chemical environments in the esophagus, pharynx and colonic areas of...

To see the full details and submit your response please register now

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Spinout Company
  • Research Project
  • Centre of Excellence
  • Academic Researcher
  • Technology

Essential information:

Submission form:

Register Now

Share this call with professional partners: